Ligand Pharmaceuticals
LGND
LGND
346 hedge funds and large institutions have $5.3B invested in Ligand Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 124 increasing their positions, 130 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
6.94% more ownership
Funds ownership: 187.67% → 194.61% (+6.9%)
6% more funds holding
Funds holding: 326 → 346 (+20)
5% less repeat investments, than reductions
Existing positions increased: 124 | Existing positions reduced: 130
Holders
346
Holding in Top 10
13
Calls
$27.5M
Puts
$19.4M
Top Buyers
| 1 | +$67.8M | |
| 2 | +$52M | |
| 3 | +$51.4M | |
| 4 |
Renaissance Technologies
New York
|
+$33M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$27.7M |
Top Sellers
| 1 | -$44.1M | |
| 2 | -$43.3M | |
| 3 | -$29M | |
| 4 |
IAM
Impax Asset Management
Portsmouth,
New Hampshire
|
-$16.2M |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$16.1M |